U.S. Health Secretary Robert F. Kennedy Jr. announced a plan to obtain federal access to state health‑information exchanges that hold millions of Americans’ medical records. The goal, according to Kennedy, is to investigate a possible link between vaccines and autism—a hypothesis that decades of research have repeatedly rejected.

HHS Requests Data from State Health‑Information Exchanges

According to KFF Health News, the Department of Health and Human Services is negotiating with at least seven state‑run exchanges to acquiire detailed, identifiable patient information, including diagnoses, lab results and prescription histories. kennedy told the outlet that such data are essential for studying autism causes, vaccine saftey and chronic disease patterns.

Privacy and Legal Concerns Raised by Public Health Leaders

Public health officials have privately warned that granting the Kennedy team access may violate privacy statutes and could be of limited scientific value .. a former CDC official warned that “giving him access to our medical records is a recipe for disaster,” while an unnamed privacy expert warned that the move could set a precedent for broader government surveillance of health data.

Historical Studies Refute Vaccine‑Autism Link

Multiple large‑scale studies, including a 2019 analysis of over 650,000 children in the Annals of Internal Medicine and a 2021 JAMA study, found no association between the MMR vaccine and autism. The American Academy of Pediatrics, CDC and WHO continue to affirm that vaccines are safe and unrelated to autism.

Funding Channels and Ideological Motives

State records show that a Nebraska nonprofit received millions of dollars to support Kennedy’s effort,though HHS has not disclosed specific research questions or data‑handling protocols.. Critics argue the push is driven more by Kennedy’s long‑standing vaccine skepticism than by new scientific inquiry.

Unanswered Questions About Data Use and Safeguards

Key uncertainties remain: How will HHS protect the identifiable health information it may receive? What concrete hypotheses will be tested, and will the study be peer‑reviewed? The administration has offered no public detail on data security or research design, leaving both privacy advocates and vaccine experts uneasy.

As the debate unfolds , the potential impact on public confidence in vaccination programs and on future federal use of health data remains a focal point for policymakers and the public alike.